These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32504774)

  • 1. Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction.
    Wright L; Barnes TJ; Prestidge CA
    Int J Pharm; 2020 Jul; 585():119488. PubMed ID: 32504774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation.
    Woitiski CB; Carvalho RA; Ribeiro AJ; Neufeld RJ; Veiga F
    BioDrugs; 2008; 22(4):223-37. PubMed ID: 18611065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery.
    Robla S; Alonso MJ; Csaba NS
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1081-1092. PubMed ID: 32478584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral drug delivery systems using chemical conjugates or physical complexes.
    Al-Hilal TA; Alam F; Byun Y
    Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.
    Pawar VK; Meher JG; Singh Y; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2014 Dec; 196():168-83. PubMed ID: 25305562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies.
    Rehmani S; Dixon JE
    Peptides; 2018 Feb; 100():24-35. PubMed ID: 29412825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral protein delivery: a patent review of academic and industrial approaches.
    Werle M; Makhlof A; Takeuchi H
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):94-104. PubMed ID: 19519570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery.
    Toorisaka E; Watanabe K; Ono H; Hirata M; Kamiya N; Goto M
    Acta Biomater; 2012 Feb; 8(2):653-8. PubMed ID: 21982846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach.
    Hens B; Bermejo M; Tsume Y; Gonzalez-Alvarez I; Ruan H; Matsui K; Amidon GE; Cavanagh KL; Kuminek G; Benninghoff G; Fan J; Rodríguez-Hornedo N; Amidon GL
    Eur J Pharm Sci; 2018 Mar; 115():258-269. PubMed ID: 29378253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Considerations in Designing Oral Drug Delivery Systems for Dogs.
    Song Y; Peressin K; Wong PY; Page SW; Garg S
    J Pharm Sci; 2016 May; 105(5):1576-1585. PubMed ID: 27056627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyelectrolyte complexes as prospective carriers for the oral delivery of protein therapeutics.
    Bourganis V; Karamanidou T; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2017 Feb; 111():44-60. PubMed ID: 27847276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
    Leonaviciute G; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in oral nanoparticle drug carrier uptake and targeting.
    Florence AT
    J Drug Target; 2004 Feb; 12(2):65-70. PubMed ID: 15203899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent patents on oral insulin delivery.
    Navgire SD; Satpute AS; Pandey S; Patil AT
    Recent Pat Drug Deliv Formul; 2014; 8(3):202-5. PubMed ID: 24981288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.